Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.38 |
| ▸ | SLC16A3 | O15427 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | SLC16A1 | P53985 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 9/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 7/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22784120 | 0.81 | HSD17B3 (0.54) | MAOBCYP19A1KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL19683465 | 0.81 | ALDH1A1 (0.39) | MAOBCYP19A1KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL20208875 | 0.79 | ALDH1A1 (0.38) | MAOBCYP19A1KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL29705980 | 0.79 | ALDH1A1 (0.38) | MAOBCYP19A1KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL21860307 | 0.79 | MAOB (0.51) | MAOBKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL24840948 | 0.78 | SLC16A3 (0.53) | MAOBCYP19A1KDM4EALDH1A1SLC16A3 | |
| SCHEMBL19685796 | 0.78 | ACHE (0.47) | MAOBCYP19A1KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL13810949 | 0.77 | CYP19A1 (0.64) | MAOBCYP19A1KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL11672559 | 0.76 | KDM4E (0.61) | MAOBKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL20209117 | 0.76 | KDM4E (0.57) | MAOBCYP19A1KDM4EALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11664171-B2 | Stilbene and fused stilbene derivatives as solar cell dyes | Ambient Photonics, Inc. (US) | 2023-05-30 | — | — | US | disclosed |
| US-20230154691-A1 | Stilbene and Fused Stilbene Derivatives as Solar Cell Dyes | Ambient Photonics, Inc. (US) | 2023-05-18 | — | — | US | disclosed |
| US-20210082632-A1 | Stilbene and Fused Stilbene Derivatives as Solar Cell Dyes | Ambient Photonics, Inc. (US) | 2021-03-18 | — | — | US | disclosed |
| US-10590100-B2 | Benzofuran derivatives for the treatment of CNS and other disorders | Ambient Photonics, Inc. (US) | 2020-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10590100-B2 | Benzofuran derivatives for the treatment of CNS and other disorders | PMP22, CDR2, CLN6 | MAOB 489/4885CYP19A1 4455/4885KDM4E 3612/4885 |
| US-20230154691-A1 | Stilbene and Fused Stilbene Derivatives as Solar Cell Dyes | FDFT1, SUN2, CDC73 | MAOB 2764/4885CYP19A1 618/4885KDM4E 2392/4885 |
| US-11664171-B2 | Stilbene and fused stilbene derivatives as solar cell dyes | SUN2, FDFT1, SIK1 | MAOB 2940/4885CYP19A1 674/4885KDM4E 1702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.